For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Kairos Pharma Ltd (AMEX: KAPA) was $0.87 for the day, down -14.12% from the previous closing price of $1.01. In other words, the price has decreased by -$14.12 from its previous closing price. On the day, 0.85 million shares were traded. KAPA stock price reached its highest trading level at $1.02 during the session, while it also had its lowest trading level at $0.8619.
Ratios:
Our analysis of KAPA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 7.16 and its Current Ratio is at 7.16. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 25 ’24 when Murali Ramachandran bought 200 shares for $1.59 per share. The transaction valued at 318 led to the insider holds 133,057 shares of the business.
Samuelson Doug bought 2,500 shares of KAPA for $3,750 on Nov 22 ’24. The Chief Financial Officer now owns 60,796 shares after completing the transaction at $1.50 per share. On Nov 20 ’24, another insider, Yu John S, who serves as the CEO and Chairman of the company, bought 4,000 shares for $1.44 each. As a result, the insider paid 5,760 and bolstered with 5,341,837 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KAPA now has a Market Capitalization of 17993140 and an Enterprise Value of 14959142.
Stock Price History:
The Beta on a monthly basis for KAPA is 2.08, which has changed by -0.24626863 over the last 52 weeks, in comparison to a change of 0.15566266 over the same period for the S&P500. Over the past 52 weeks, KAPA has reached a high of $3.25, while it has fallen to a 52-week low of $0.40. The 50-Day Moving Average of the stock is -33.04%, while the 200-Day Moving Average is calculated to be -16.37%.
Shares Statistics:
KAPA traded an average of 1.01M shares per day over the past three months and 255600 shares per day over the past ten days. A total of 17.74M shares are outstanding, with a floating share count of 8.69M. Insiders hold about 58.11% of the company’s shares, while institutions hold 1.05% stake in the company. Shares short for KAPA as of 1760486400 were 274895 with a Short Ratio of 0.27, compared to 1757894400 on 361699. Therefore, it implies a Short% of Shares Outstanding of 274895 and a Short% of Float of 1.97.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 2.0 analysts currently analyzing and rating the stock of Kairos Pharma Ltd (KAPA).The consensus estimate for the next quarter is -$0.08, with high estimates of -$0.03 and low estimates of -$0.12.
Analysts are recommending an EPS of between -$0.19 and -$0.29 for the fiscal current year, implying an average EPS of -$0.24. EPS for the following year is -$0.37, with 2.0 analysts recommending between -$0.33 and -$0.4.
